Advancing Off-The-Shelf Immunotherapy for Solid Tumors: Using Gene-Edited iNK Cells
Time: 3:30 pm
day: Day Two
- What are the important features for product-centric, ‘off-the-shelf’ immunotherapy, and how can we create this?
- Establishing gene-editing and manufacture systems for functionally enhanced iPSC derived iNK cells
- Translating allogeneic products to the clinic: the development of CTH-401